Resultados de búsqueda - Adriana Gasca
- Mostrando 1 - 2 Resultados de 2
-
1
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor–Positive, <i>ERBB2</i>-Negative Meta... por Elisabetta Munzone, Meredith M. Regan, Saverio Cinieri, Emilia Montagna, Laura Orlando, R. Shi, Enrico Campadelli, Lorenzo Gianni, Michela Palleschi, Fausto Petrelli, Carmelo Bengala, Daniele Generali, Elena Collovà, Fabio Puglisi, Elisabetta Cretella, Claudio Zamagni, Claudio Chini, Barbara Ruepp, Sherene Loi, Marco Colleoni, Angelo Di Leo, Rolf A. Stahel, Stefan Aebi, Paul Baas, Richard D. Gelber, Keith McGregor, Solange Peters, Sanjay Popat, R. Rosell, Anita Hiltbrunner, G Achille, Anne Carrer-Wagner, Daniela Celotto, Carmen Comune, Adriana Gasca, Nino Giacomelli, Roswitha Kammler, Rita Pfister, Heidi Roschitzki, Monica Ruggeri, Elizabeth Rugiati, Mirjam Schneider, Judith Schroeder, Sandra Troesch, Colleen Bouzan, Subrina Farah, Zhuoxin Sun, Holly Shaw, L. J. Blacher, Colleen King, Leslie Mundy, Dorene Polizzi, Mónica Greco, Karolyn Scott, Robert Starkweather, R. Ghisini, Roberto Masetti, Laura Amaducci, Ugo De Giorgi, Graziella Pinotti, Michela Donadio, Aron Goldhirsch
Publicado 2023Artigo -
2
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutat... por Ross A. Soo, Ji‐Youn Han, Urania Dafni, Byoung Chul Cho, Chong Ming Yeo, Ernest Nadal, Enric Carcereny, Javier de Castro, María Ángeles Sala, Reyes Bernabé, Linda Coate, Mariano Provencio, Rosario García Campelo, Sinéad Cuffe, Sayed M.S. Hashemi, Martin Früh, Bartomeu Massutí, José García-Sánchez, Manuel Dómine, Margarita Majem, J.M. Sánchez-Torres, Christian Britschgi, Miklos Pless, Georgia Dimopoulou, Heidi Roschitzki‐Voser, Barbara Ruepp, Rafael Rosell, Rolf A. Stahel, Solange Peters, Rolf A. Stahel, Solange Peters, Ross A. Soo, Ji‐Youn Han, Martin Früh, Mariano Provencio, Linda Coate, Urania Dafni, Anita Hiltbrunner, Barbara Ruepp, Heidi Roschitzki‐Voser, Anita Hiltbrunner, Adriana Gasca-Ruchti, Nino Giacomelli, Rosita Kammler, Nesa Marti, Lionel Nobs, Mariana Pardo-Contreras, Rita Pfister, Anne‐Christine Piguet, Sabrina Ribeli-Hofmann, Virginia Rodriguez Martinez, Heidi Roschitzki‐Voser, Susanne Roux, Barbara Ruepp, Magdalena Sánchez-Hohl, Mirjam Schneider, Robin Schweri, Sandra Troesch, Isabel Zigomo, Urania Dafni, Zoi Tsourti, Panagiota Zygoura, Marie Kassapian, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, María Teresa Sariñena Fernandez, Eva Pereira, Carolina Simona, Lisa Tucker, Jillian Burnes, Aisling Barrett, Meghan McGrillen, Catherine Berset, Christine Biaggi, M. Reist, Priska Rentsch, Linda Coate, Sinéad Cuffe, Sayed M.S. Hashemi, Ernest Nadal, Enric Carcereny, Javier de Castro, María Ángeles Sala, Reyes Bernabé, Mariano Provencio, Rosario García Campelo, Bartomeu Massutí, José López García, Manuel Dómine, Margarita Majem, José Miguel Sánchez, Martin Früh, Christian Britschgi, Miklos Pless, Solange Peters, Ross A. Soo, Chong Ming Yeo, Ji‐Youn Han, Byoung Chul Cho
Publicado 2021Artigo
Herramientas de búsqueda:
Materias Relacionadas
Cancer
Chemotherapy
Internal medicine
Medicine
Oncology
A549 cell
Adverse effect
Bevacizumab
Breast cancer
Capecitabine
Chemotherapy regimen
Cisplatin
Clinical endpoint
Clinical trial
Colorectal cancer
Confidence interval
Cyclophosphamide
Environmental health
Epidermal growth factor receptor
Erlotinib
Gefitinib
Hazard ratio
Lung cancer
Metastatic breast cancer
Osimertinib
Population
Progression-free survival
Regimen
Surgery
T790M